Publications

Want to be in the know about the latest advances in diabetes research? Need more information on how to live well with T1D? Connect with us on social networking sites, subscribe to our emails, and check out our print and online materials.



Countdown

  • JDRF Honors Pioneering Type 1 Diabetes Researchers with Annual Awards

    A Beta Cell Therapy Research Team, Immunologist and Diabetes Organ Donor Network Are Among the Recipients JDRF recently presented its prestigious annual research awards to a diverse group of scientists and organizations whose innovative work is moving us closer to a world without type 1 diabetes (T1D). Presented in mid-January in Los Angeles, the three […]

    Read More

  • Unlocking a Combination Therapy for New Onset T1D

    A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and granulocyte colony stimulating factor […]

    Read More

  • Engineering a Better Shield for Beta Cells

    Researchers discovered a protein shield that may enhance the protective barrier of encapsulated islets for type 1 diabetes A new technology for encapsulating islets or beta cells using the human protein called CXCL12 could result in improved encapsulated cell replacement therapies for individuals with type 1 diabetes (T1D). JDRF-supported researcher Dr. Mark C. Poznansky, Associate […]

    Read More

  • A song worth more than a listen

    Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

    Read More

  • Advancing a Key Artificial Pancreas Technology

    Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]

    Read More